Table 1. Baseline characteristics.
| Variable | n | Mean ± SEM |
|---|---|---|
| Participant number (n) [F/M] | 38 [26/12] | |
| Age (years) | 38 | 73 ± 0.96 |
| BMI (kg/m2) | 38 | 28 ± 0.59 |
| Waist circumference (cm) | 36 | 91 ± 1.58 |
| Currently smoking (n) [%] | 38 | 2 [5] |
| Caucasian ethnicity (n) [%] | 38 | 38 [100] |
| Cholesterol medication (n) [%] | 38 | 13 [34] |
| Antihypertensive medication (n) [%] | 38 | 15 [39] |
| Heart disease medication (n) [%] | 38 | 10 [26] |
| tOC (ng/ml) | 37 | 21 ± 1.31 |
| ucOC (ng/ml) | 37 | 8 ± 0.61 |
| ucOC/tOC ratio | 37 | 0.39 ± 0.01 |
| Systolic BP (mmHg) | 38 | 139 ± 2.53 |
| Diastolic BP (mmHg) | 38 | 79 ± 1.43 |
| MAP (mmHg) | 38 | 98 ± 1.74 |
| PWV (m/s) | 34 | 8 ± 0.28 |
| BAFMD–peak dilation (%) | 29 | 4.62 ± 0.44 |
| BAFMD–time to peak dilation (s) | 29 | 58 ± 2.56 |
Abbreviations: BMI; Body mass index, tOC; total osteocalcin, ucOC; undercarboxylated osteocalcin, BP; blood pressure, MAP; mean arterial pressure, PWV; pulse wave velocity, BAFMD; brachial artery flow mediated dilatation.